Upcoming Earnings: Q2 '26
Estimated EPS
-$0.57
Estimated Rev
$0.42M
$VNRX Q1 '26 Earnings Results & Recap VolitionRX Ltd reported total revenues of $985,076 for Q1 2026, a significant increase from $246,385 in Q1 2025, driven by product sales. Net loss increased to $6.7M from $5.5M year-over-year. Cash and cash equivalents reached $3.1M.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.57 | -- | -- | N/A |
Q1 '26 | -$0.73 | -$0.97 | -32.88% | MISSED |
Q4 '25 | -$0.04 | -- | -- | N/A |
Q3 '25 | -$0.04 | -$0.05 | -13.64% | MISSED |
Q2 '25 | -$0.06 | -$0.06 | -7.14% | MISSED |